Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2019-11-15FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a Supplemental Application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2019-11-15FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved Novo Nordisk's supplemental application for NOVOLIN R (human insulin).
-
FDA approval · 2019-11-15FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2019-11-15FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for APIDRA (insulin glulisine) from Sanofi-Aventis U.S. LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-15FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2019-09-10FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Original Application (Xeris Pharmaceuticals, Inc.)
FDA approved GVOKE HYPOPEN 0.5 mg Auto-Injector (glucagon injection, solution) from Xeris Pharmaceuticals in an original application (NDA212…
-
FDA approval · 2019-09-09FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for GLUCAGON submitted by Fresenius Kabi USA, LLC. The approval updates labeling and/or administ…
-
FDA approval · 2019-08-22FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly. The approval corresponds to changes described in t…
-
FDA approval · 2019-08-22FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2019-08-13FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2019-07-24FDA Approved: BAQSIMI — Original Application (Amphastar Pharmaceuticals, Inc.)
FDA approved BAQSIMI (glucagon) from Amphastar Pharmaceuticals in an Original Application for the treatment of severe hypoglycemia in people…
-
FDA approval · 2019-06-20FDA Approved: MYXREDLIN — Original Application (Baxter Healthcare Corporation)
FDA approved MYXREDLIN (insulin human) from Baxter Healthcare Corporation through an original application for use in the treatment of diabet…
-
FDA approval · 2018-12-20FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for insulin aspart protamine and insulin aspart mix 70/30 from Novo Nordisk Pharma, Inc.
-
FDA approval · 2018-12-20FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2018-11-06FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2018-11-06FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2018-11-06FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company, indicating an update to the product labeli…
-
FDA approval · 2018-11-01FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog KwikPen (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2018-11-01FDA Approved: ADMELOG — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for ADMELOG (insulin lispro) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2018-09-24FDA Approved: FIASP — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for FIASP (insulin aspart injection) from Novo Nordisk.
-
FDA approval · 2018-06-01FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Novo Nordisk's Novolin 70/30 (human insulin), updating the product's regulatory status.
-
FDA approval · 2017-06-06FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog KwikPen (insulin lispro) from Eli Lilly and Company. The approval likely covers changes …
-
FDA approval · 2017-01-06FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly, updating the product's labeling and approval detai…
-
FDA approval · 2016-11-18FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN R (human insulin) from Novo Nordisk.